A Clinical Trial Using a New Medical Device to Evaluate Its Impact on IV Care and Clinical Complications

Inclusion Criteria: * All patients admitted into the participating hospital units * Patients of any gender may participate * Participants able to provide informed consent or have a legally authorized representative immediately available to provide informed consent * Patients must have peripheral IV catheter access or need and are planned to have peripheral IV catheter access placed that is anticipated to last a minimum of 24 hours. * Patients must be receiving intermittent or continuous infusion or have immediate plans to begin an intermittent or continuous infusion * The patients must be at least 18 years of age with no upper age limit Exclusion Criteria: * Unable to obtain informed consent or without an available Legally Authorized Representative or Next of Kin to provide surrogate informed consent * Age less than or equal to 17 * Patient on comfort care only * Predicted to have an IV infusion that lasts less than 24 hours * Patient admitted from the Emergency Department refuses to have new peripheral IV catheter placed by IV team * Patient has two or more peripheral IV catheters at the same time * Patient enrolled in a subject drug or device study at the time of enrollment * Investigator discretion that patient is not suitable for the study * Patient is COVID-19 positive * Patient is receiving an IV infusion with gravity tubing